Tamoxifen for patients with estrogen receptor-negative breast cancer

被引:0
|
作者
Swain, SM [1 ]
机构
[1] NCI, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:93S / 97S
页数:5
相关论文
共 50 条
  • [41] Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer
    Nikoic-Vukosavljevic, D
    Kanjer, K
    Neskovic-Konstantinovic, Z
    Vukotic, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 196 - 200
  • [42] Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status
    Noh, Songmi
    Kim, Ji-Ye
    Koo, Ja Seung
    TUMOR BIOLOGY, 2014, 35 (08) : 8179 - 8192
  • [43] Estrogen Receptor Positive and Progesterone Receptor-negative Breast Cancer: The Role of Hormone Therapy
    Habibi, Mehran
    Canner, Joseph
    Dembinski, Robert
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S467 - S467
  • [44] Activation of the Glucocorticoid Receptor Is Associated with Poor Prognosis in Estrogen Receptor-Negative Breast Cancer
    Pan, Deng
    Kocherginsky, Masha
    Conzen, Suzanne D.
    CANCER RESEARCH, 2011, 71 (20) : 6360 - 6370
  • [45] Morphologic spectrum of estrogen receptor-negative breast carcinoma
    Scawn, R
    Shousha, S
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2002, 126 (03) : 325 - 330
  • [46] Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumor: being younger and getting less benefit from adjuvant tamoxifen treatment
    Yu, K.
    Di, G.
    Wu, J.
    Lu, J.
    Shen, K.
    Shen, Z.
    Shao, Z.
    EJC SUPPLEMENTS, 2008, 6 (07): : 182 - 182
  • [47] A genome-wide association scan on estrogen receptor-negative breast cancer
    Li, Jingmei
    Humphreys, Keith
    Darabi, Hatef
    Rosin, Gustaf
    Hannelius, Ulf
    Heikkinen, Tuomas
    Aittomaki, Kristiina
    Blomqvist, Carl
    Pharoah, Paul D. P.
    Dunning, Alison M.
    Ahmed, Shahana
    Hooning, Maartje J.
    Hollestelle, Antoinette
    Oldenburg, Rogier A.
    Alfredsson, Lars
    Palotie, Aarno
    Peltonen-Palotie, Leena
    Irwanto, Astrid
    Low, Hui Qi
    Teoh, Garrett H. K.
    Thalamuthu, Anbupalam
    Kere, Juha
    D'Amato, Mauro
    Easton, Douglas F.
    Nevanlinna, Heli
    Liu, Jianjun
    Czene, Kamila
    Hall, Per
    BREAST CANCER RESEARCH, 2010, 12 (06)
  • [48] Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer
    YAO Chen LIN Ying YE Caisheng BI Jiong ZHU Yifan WANG Shenming Division of Breast SurgeryDepartment of SurgeryFirst Affiliated HospitalSun Yatsen UniversityGuangzhou China Yao CLin YYe CSBi JZhu YF and Wang SM
    Chinese Medical Journal, 2007, 120 (20) : 1766 - 1772
  • [49] Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer
    Chen, Yao
    Ying, Lin
    Ye Cai-Sheng
    Jiong, Bi
    Zhu Yi-Fan
    Wang Shen-Ming
    CHINESE MEDICAL JOURNAL, 2007, 120 (20) : 1766 - 1772
  • [50] Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
    Yu, Ke-da
    Di, Gen-hong
    Wu, Jiong
    Lu, Jin-song
    Shen, Kun-wei
    Liu, Guang-yu
    Shen, Zhen-zhou
    Shao, Zhio-ming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (12) : 1347 - 1354